PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
David Planchard, MD, PhD - Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
Visit https://www.peervoice.com/HGF860 to view the entire programme with slides. After completing “David Planchard, MD, PhD - Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting”, participants will be able to: Explain the rationale for use of CEACAM5-directed therapies in the treatment of NSCLC; Identify recommended approaches for detection of CEACAM5 expression in patients with NSCLC; and Evaluate available efficacy and safety data from clinical trials evaluating CEACAM5-directed therapies for NSCLC.